Welcome back! If you missed our 2022 re-cap in part one of this blog series, you can find it here. If you’re already caught up…

Nulla quis lorem ut libero malesuada feugiat. Donec rutrum congue leo eget malesuada. Nulla quis lorem ut libero malesuada feugiat. Curabitur arcu erat, accumsan id imperdiet et, porttitor at sem. Curabitur non nulla sit amet nisl tempus convallis quis.
Welcome back! If you missed our 2022 re-cap in part one of this blog series, you can find it here. If you’re already caught up…
We couldn’t be more excited about 2023, but before we move forward, let’s take a look back at all our accomplishments.
So, let’s wrap up the incredible, unpredictable and unprecedented year 2022 with the eyes of a winner!
Medical Device Manufacturers in the US have many questions as the Dec 8, 2022 GUDID compliance deadline approaches. This blog will answer some of the most common questions, and ensure everyone has the answers they need to begin their journey toward the FDA’s GUDID Class I Compliance.
The FDA will enforce the GUDID submission requirements for Class I and unclassified devices, other than implantable, life-supporting or life-sustaining devices, regardless of whether they are consumer health products, on December 8, 2022.
There is no excerpt because this is a protected post.
Brazil’s medical device market regulator, ANVISA announced major updates to its Resolution of the Collegiate Board of Directors (RDC) 185/2001.
Australia is establishing a unique identification system for medical devices and its regulator, the Therapeutic Goods Administration (TGA) issued several updates regarding Unique Device Identification (UDI) regulations, Essential Principles for compliance requirements and guidelines for active medical devices.